Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction–Associated Steatotic Liver Disease ( <scp>MASLD</scp> )
Kaleb Tesfai(University of California San Diego), Veeral Ajmera(University of California San Diego), Luis Antonio Díaz(Pontificia Universidad Católica de Chile), Mísia Joyner de Sousa Dias Monteiro(University of California San Diego), Adrián Gadano(Hospital Italiano de Buenos Aires), Amit V. Khera(Broad Institute), Gil F. Salles(Universidade Federal do Rio de Janeiro), Nathalie C. Leite(Universidade Federal do Rio de Janeiro), Fernando Javier Barreyro(Mayo Clinic), Mário Reis Álvares‐da‐Silva(Universidade Federal do Rio Grande do Sul), Francisco Idalsoaga, Mário Guimarães Pessôa(Universidade de São Paulo), Saaket Agrawal(Massachusetts General Hospital), Juan Pablo Arab(Pontificia Universidad Católica de Chile), Cláudia Alves Couto(University of California San Diego), Rohit Loomba(University of California San Diego), Marco Arrese(Pontificia Universidad Católica de Chile), Seema Singh(University of Mississippi Medical Center), Claudia Regina Cardoso(Hospital Universitário Clementino Fraga Filho), Cristiane Alves Villela‐Nogueira(Universidade Federal do Rio de Janeiro), Sebastián Marciano(Hospital Italiano de Buenos Aires), Ricki Bettencourt(University of California San Diego), Cláudia P. Oliveira(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Gustavo Ayares(Pontificia Universidad Católica de Chile), Rafael Theodoro(University of California San Diego), Jorge Martínez Morales(Hospital Italiano de Buenos Aires), Egbert Madamba(University of California San Diego), Lisa Richards(University of California San Diego), Daniel Q. Huang(National University of Singapore)
Cited by 9
Related Papers
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
|Nature Genetics|2018|3.1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k